Chart calendar Aligos Therapeutics, Inc.

87c184cb1c3950.7TppYl7cWrweQ7KCWeAaG0OTt4956qTdUSud5WIT0AY.3HYlJzK1d91nKvr2LaZNcQj1wbYwoubsGm_TqBAgnXyhXlEEHLAJ7VEahg~43ea66669d8d9430e52c1bf328f6dc93

Upcoming events on Aligos Therapeutics, Inc.

No events available

Past events on Aligos Therapeutics, Inc.

2026-08-06

Earnings release - Q2 2026

2026-06-25

Présentation aux Actionnaires / Analystes

11:00
2026-06-25

Annual General Meeting

11:00
2026-05-07

Earnings release - Q1 2026

2026-03-05

Earnings release - Q4 2025

Annual results

Fiscal PeriodDecember 2023 2024 2025 2026 2027 2028
Net sales
Million USD
Released
Forecast
Spread
9,34
14,4
-35.26%
3,95
3,74
5.37%
2,19
2,45
-10.66%

36,0


4,65


52,1

EBITDA
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
-87,1
-93,4
6.81%

-93,0


-119


-128

EBIT
Million USD
Released
Forecast
Spread
-88,1
-80,8
-9.11%
-89,2
-91,6
2.63%
-88,0
-92,8
5.21%

-84,9


-128


-104

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-86,9
-77,6
-11.96%
-131
-70,8
-84.9%
-23,9
-59,7
59.99%

-77,1


-125


-101

Net income
Million USD
Released
Forecast
Spread
-87,7
-77,8
-12.75%
-131
-71,1
-84.58%
-24,2
-45,2
46.51%

-79,3


-125


-101

EPS
USD
Released
Forecast
Spread
-34,0
-41,3
17.58%
-20,9
-10,1
-107.46%
-2,45
-5,01
51.09%

-6,48


-5,37


-2,61

Announcement Date12/03/2410/03/2505/03/26-

Quarterly results

Fiscal PeriodJune 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4 2027 Q1 2027 Q2 2027 Q3 2027 Q4
Net sales
Million USD
Released
Forecast
Spread
0,63
0,43
45.15%
0,31
0,50
-37.8%
0,97
0,43
122.69%
0,74
0,50
48.2%
0,17
0,27
-36.63%
2,83
0,25
1032%
27,8
14,7
89.37%

5,54


0,61


0,22


0,22


0,91


4,42

EBITDA
Million USD
Released
Forecast
Spread









-28,1
-23,5
-19.75%
-21,6
-28,1
23.22%
-26,6
-24,7
-7.65%
-1,64
-7,40
77.91%

-32,0


-33,0













EBIT
Million USD
Released
Forecast
Spread
-20,6
-23,0
10.47%
-19,2
-21,6
10.85%
-18,6
-21,6
14.11%
-28,4
-21,1
-34.56%
-21,8
-26,7
18.17%
-26,9
-24,1
-11.63%
-1,89
-15,7
87.98%

-25,3


-30,8


-31,2


-32,1


-32,4


-34,7

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-82,1
-22,0
-272.52%
43,1
-21,3
302.76%
-15,7
-21,3
26.34%
-31,5
-20,0
-57.37%
-19,9
-26,2
24.16%
-22,7
-23,5
3.3%
1,31
-14,8
108.82%

-24,7


-30,0


-30,0


-31,0


-31,4


-30,3

Net income
Million USD
Released
Forecast
Spread
-82,2
-22,0
-272.64%
43,1
-21,3
302.56%
-15,9
-21,3
25.47%
-31,5
-20,0
-57.65%
-19,9
-26,2
24.04%
-23,0
-23,5
1.99%
-1,50
-14,8
89.85%

-24,7


-29,4


-30,0


-31,0


-31,4


-30,3

EPS
USD
Released
Forecast
Spread
-13,1
-2,50
-424.7%
5,12
-2,98
271.96%
-1,53
-2,36
35.26%
-3,04
-1,90
-60%
-1,91
-2,03
5.9%
-2,21
-2,23
0.9%
-0,14
-1,09
87.2%

-2,28


-1,92


-1,71


-1,74


-1,35


-1,10

Announcement Date10/03/2506/05/2506/08/2506/11/2505/03/2607/05/2606/08/26------
2026-11-09

Earnings release - Q3 2026

2026-11-09

Earnings presentation

09:00
2026-11-09

Earnings release - Q3 2026

2026-11-09

Earnings release - Q2 2027

2026-11-09

Earnings presentation

08:00
2026-11-09

Earnings presentation

16:30
2026-11-09

Earnings release - Q3 2026

2026-11-09

Earnings release - Q3 2026

2026-11-09

Earnings presentation

17:00
2026-11-09

Information meeting

08:00

Past sector events for Aligos Therapeutics, Inc.

2026-11-06

Présentation aux Actionnaires / Analystes

08:00
2026-11-06

Présentation aux Actionnaires / Analystes

16:35
2026-11-06

Earnings presentation

02:00
2026-11-05

Earnings presentation

08:00
2026-11-05

Earnings release - Q3 2026

2026-11-05

Extraordinary General Meeting

2026-11-05

Earnings release - Q2 2027

2026-11-05

Earnings presentation

07:00
2026-11-05

Earnings presentation

16:30
2026-11-05

Earnings release - Q3 2026

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Aligos Therapeutics, Inc.

Net sales - Rate of surprise

Rate of surprise - Net sales - Annual - Aligos Therapeutics, Inc.

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Aligos Therapeutics, Inc.
  1. Stock Market
  2. Stocks
  3. ALGS Stock
  4. Calendar Aligos Therapeutics, Inc.